abrdn Life Sciences Investors (HQL) to Issue Quarterly Dividend of $0.56 on June 30th

abrdn Life Sciences Investors (NYSE:HQL) declared a quarterly dividend on Monday, May 11th. Stockholders of record on Thursday, May 21st will be given a dividend of 0.56 per share on Tuesday, June 30th. This represents a c) annualized dividend and a dividend yield of 12.7%. The ex-dividend date is Thursday, May 21st.

abrdn Life Sciences Investors Price Performance

NYSE HQL opened at $17.66 on Tuesday. The firm has a 50 day simple moving average of $17.16 and a 200-day simple moving average of $17.01. abrdn Life Sciences Investors has a one year low of $12.12 and a one year high of $18.46.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Penserra Capital Management LLC boosted its stake in shares of abrdn Life Sciences Investors by 3.2% in the third quarter. Penserra Capital Management LLC now owns 794,138 shares of the company’s stock valued at $12,317,000 after purchasing an additional 24,481 shares during the period. LPL Financial LLC boosted its stake in shares of abrdn Life Sciences Investors by 20.0% in the fourth quarter. LPL Financial LLC now owns 448,846 shares of the company’s stock valued at $7,532,000 after purchasing an additional 74,787 shares during the period. Raymond James Financial Inc. boosted its stake in shares of abrdn Life Sciences Investors by 12.5% in the third quarter. Raymond James Financial Inc. now owns 423,031 shares of the company’s stock valued at $6,561,000 after purchasing an additional 47,071 shares during the period. Flagship Harbor Advisors LLC boosted its stake in shares of abrdn Life Sciences Investors by 1.8% in the fourth quarter. Flagship Harbor Advisors LLC now owns 363,381 shares of the company’s stock valued at $6,098,000 after purchasing an additional 6,257 shares during the period. Finally, Allspring Global Investments Holdings LLC boosted its stake in shares of abrdn Life Sciences Investors by 57.3% in the first quarter. Allspring Global Investments Holdings LLC now owns 362,535 shares of the company’s stock valued at $5,898,000 after purchasing an additional 132,098 shares during the period. Hedge funds and other institutional investors own 32.21% of the company’s stock.

About abrdn Life Sciences Investors

abrdn Life Sciences Investors (NYSE: HQL) is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.

The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.